|
1
|
Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells.
|
J Immunol
|
2003
|
0.96
|
|
2
|
Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins.
|
Prostaglandins Leukot Essent Fatty Acids
|
2005
|
0.95
|
|
3
|
5-Aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors.
|
Bioorg Med Chem Lett
|
2012
|
0.90
|
|
4
|
Synthesis and pharmacological characterization of novel druglike corticotropin-releasing factor 1 antagonists.
|
J Med Chem
|
2008
|
0.85
|
|
5
|
Identification of novel NK1/NK3 dual antagonists for the potential treatment of schizophrenia.
|
Bioorg Med Chem Lett
|
2011
|
0.84
|
|
6
|
Identification of 2-(4-pyridyl)thienopyridinones as GSK-3β inhibitors.
|
Bioorg Med Chem Lett
|
2011
|
0.78
|
|
7
|
Azabicyclo[3.1.0]hexane-1-carbohydrazides as potent and selective GHSR1a ligands presenting a specific in vivo behavior.
|
ChemMedChem
|
2011
|
0.78
|
|
8
|
Stereospecific synthesis and structure-activity relationships of unsymmetrical 4,4-diphenylbut-3-enyl derivatives of nipecotic acid as GAT-1 inhibitors.
|
Bioorg Med Chem Lett
|
2010
|
0.77
|
|
9
|
Dihydropyrrole[2,3-d]pyridine derivatives as novel corticotropin-releasing factor-1 antagonists: mapping of the receptor binding pocket by in silico docking studies.
|
J Med Chem
|
2008
|
0.77
|